Thymosin Alpha-1 10mg
Original price was: 69,99 €.55,99 €Current price is: 55,99 €.
Thymosin Alpha-1 Europe
T?1 · Thymic Peptide · T-Cell & Immune Modulation Research
Thymosin Alpha-1 Europe is supplied by Baltic Peptides as a lyophilised research compound at ≥99% analytical purity, independently verified by third-party HPLC and mass spectrometry analysis. Thymosin Alpha-1 (T?1) is a 28-amino acid peptide originally isolated from thymosin fraction 5, a bovine thymic extract first characterised by Goldstein et al. in the 1970s. The peptide is encoded within the prothymosin alpha gene and is processed post-translationally by cleavage of the larger precursor protein. Endogenous T?1 is produced primarily in the thymus and plays a role in T-lymphocyte maturation and immune regulation. Baltic Peptides supplies Thymosin Alpha-1 Europe as a synthetic lyophilised research peptide at ≥99% HPLC-verified purity, independently confirmed by third-party mass spectrometry.
This compound is made available exclusively for in vitro and preclinical research purposes by qualified scientific investigators and licensed research institutions.
Third-Party Verified · COA Available · EU Dispatch
Analytical Purity
HPLC · Mass Spec Verified
Key Features
Researchers choosing Thymosin Alpha-1 Europe from Baltic Peptides receive a ≥99% HPLC-verified, independently tested research compound dispatched from within the EU. Key specifications for Thymosin Alpha-1 Europe are summarised below.
-
Purity — ≥99% by HPLC analysis
-
Form — Lyophilised powder, single-use vials
-
Storage (long-term) — −20 °C, desiccated, protected from light
-
Storage (short-term) — 2–8 °C, up to 4 weeks
-
Solubility — Sterile water or PBS (≥1 mg/mL)
-
Classification — Research Use Only (RUO)
-
Testing — Independent third-party batch verification
-
Documentation — Certificate of Analysis (COA) per batch
Scientific Overview — Thymosin Alpha-1 Europe
Compound Background
Thymosin Alpha-1 — Thymic Origin
Thymosin Alpha-1 (T?1) is a 28-amino acid peptide originally isolated from thymosin fraction 5, a bovine thymic extract first characterised by Goldstein et al. in the 1970s. The peptide is encoded within the prothymosin alpha gene and is processed post-translationally by cleavage of the larger precursor protein. Endogenous T?1 is produced primarily in the thymus and plays a role in T-lymphocyte maturation and immune regulation. Baltic Peptides supplies Thymosin Alpha-1 Europe as a synthetic lyophilised research peptide at ≥99% HPLC-verified purity, independently confirmed by third-party mass spectrometry.
Primary Research Domains
Thymosin Alpha-1 Europe research has been documented across the following interconnected domains in preclinical model systems:
Signalling Pathway — Research Context
The mechanistic cascade most consistently associated with Thymosin Alpha-1 Europe in preclinical research:
Thymosin Alpha-1 — T?1
T-Cell Maturation / TLR Signalling
Th1 Polarisation / NK Cell Activation
Antiviral / Immune Modulation
Technical Specifications — Thymosin Alpha-1 Europe
| Parameter | Specification |
|---|---|
| Compound Name | Thymosin Alpha-1 (T?1) |
| Sequence / Composition | Ac-Ser-Asp-Ala-Ala-Val-Asp-Thr-Ser-Ser-Glu-Ile-Thr-Thr-Lys-Asp-Leu-Lys-Glu-Lys-Lys-Glu-Val-Val-Glu-Glu-Ala-Glu-Asn-OH |
| Molecular Formula | C129H215N33O55 |
| Molecular Weight | ~3108.5 g/mol |
| CAS Number | 62304-98-7 |
| Purity | ≥99% (HPLC verified per batch) |
| Form | Lyophilised powder |
| Appearance | White to off-white lyophilised powder |
| Solubility | Sterile water or PBS (≥1 mg/mL) |
| Long-Term Storage | −20 °C, desiccated, protected from light |
| Short-Term Storage | 2–8 °C, sealed vial, up to 4 weeks |
| Reconstituted Stability | Up to 14 days at 2–8 °C; avoid freeze-thaw cycling |
| Research Classification | Research Use Only (RUO) |
| Supplier | Baltic Peptides — EU dispatch from Lithuania |
Thymosin Alpha-1 Europe — Lab Testing & Quality Assurance
Each Baltic Peptides batch of Thymosin Alpha-1 Europe undergoes independent multi-method analytical verification at a third-party accredited laboratory prior to release. Full analytical documentation is provided per lot, ensuring complete traceability from synthesis through to dispatch.
HPLC Purity Analysis
Reverse-phase HPLC confirms ≥99% purity with quantified impurity profiling and peak area analysis. All relevant degradation products and synthesis-related impurities are monitored.
Mass Spectrometry
High-resolution ESI-MS confirms the correct molecular mass and sequence identity of Thymosin Alpha-1 Europe, providing orthogonal identity confirmation independent of purity measurement.
Certificate of Analysis
A batch-specific COA documenting HPLC purity data, mass spectrometry identity confirmation, lot number, manufacturing and testing dates, and method references is issued per production lot.
Third-Party Verification
All analytical data for Thymosin Alpha-1 Europe is generated by independent accredited external laboratories, providing researchers with fully auditable, conflict-free quality documentation for each production batch.
Storage & Handling — Thymosin Alpha-1 Europe
Thymosin Alpha-1 is a relatively stable 28-mer peptide when stored correctly. Appropriate storage and handling protocols preserve the analytical specification of Thymosin Alpha-1 Europe throughout its research lifecycle. Follow the guidelines below:
Lyophilised (Unopened)
Store at −20 °C, desiccated. Stable for 24 months from manufacture date when stored correctly. Protect from light and moisture.
Short-Term (Unopened)
2–8 °C acceptable for up to 4 weeks in the sealed vial. Retain original light-protective packaging until use.
Reconstituted Solution
Store at 2–8 °C in a closed, light-protected container. Use within 14 days of reconstitution. Avoid freeze-thaw cycling.
Reconstitution
Add solvent slowly along the vial wall and swirl gently — do not vortex. Use Sterile water or PBS (≥1 mg/mL) as the reconstitution vehicle.
Research Use Only — Important Notice
All products supplied by Baltic Peptides are designated exclusively for in vitro research, preclinical investigation, and laboratory study by qualified professionals operating within appropriately licensed or regulated research environments.
Thymosin Alpha-1 Europe is not approved for human or veterinary therapeutic use by any national medicines regulatory authority, including the EMA, FDA, or MHRA. It has not been evaluated in registered human clinical trials and is not intended for self-administration, clinical application, or any use outside of legitimate controlled scientific research.
By completing a purchase, the buyer confirms their status as a qualified researcher and explicitly acknowledges the research-use-only classification of this compound. Baltic Peptides assumes no liability for any use of this product beyond its stated research designation.
Frequently Asked Questions — Thymosin Alpha-1 Europe
What is Thymosin Alpha-1 used for in research?
Thymosin Alpha-1 Europe is investigated in immunology research covering T-cell differentiation, TLR signalling, antiviral immune responses, NK cell activation, and immunosenescence models. It is not approved for therapeutic use in the research context supplied here.
What is the difference between Thymosin Alpha-1 and Thymalin?
Thymosin Alpha-1 (T?1) is a specific, sequenced 28-amino acid synthetic peptide derived from prothymosin alpha. Thymalin is a polypeptide complex extracted from bovine thymus tissue, containing multiple peptide fractions rather than a single defined sequence. T?1 provides sequence-specific research utility; Thymalin provides a broader thymic polypeptide profile.
Is a Certificate of Analysis available?
Yes. Every Baltic Peptides lot of Thymosin Alpha-1 Europe is supplied with a batch-specific COA documenting HPLC purity (≥99%), ESI-MS identity confirmation, lot number, and testing dates.
How should Thymosin Alpha-1 be stored?
Store lyophilised T?1 at −20 °C, desiccated and protected from light. Reconstituted solutions should be kept at 2–8 °C and used within 14 days. Avoid freeze-thaw cycling.
Is Thymosin Alpha-1 Europe available with a Certificate of Analysis?
Yes. Baltic Peptides issues a batch-specific Certificate of Analysis for every production lot of Thymosin Alpha-1 Europe. Each COA documents HPLC purity data, mass spectrometry identity confirmation, lot number, manufacturing and testing dates, and the analytical method parameters applied by the third-party testing laboratory. COAs are available upon request or can be accessed directly via the Baltic Peptides COA page.
What are the shipping conditions for Thymosin Alpha-1 Europe?
Thymosin Alpha-1 Europe is dispatched in lyophilised form from within the EU, providing shorter transit times and reduced customs exposure for European research institutions. All Baltic Peptides orders are packaged with temperature-protective and light-protective materials appropriate for research peptide compounds. Fully tracked shipping with EU dispatch from Lithuania.





